Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KYMRKymera Therapeutics, Inc.

Nasdaq · CIK 0001815442
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts215

Identity from submissions API

NameKymera Therapeutics, Inc.
CIK0001815442
TickersKYMR
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN812992166
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-285-5314
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Kymera Therapeutics, Inc. (2020-06-22T04:00:00.000Z → 2026-10-29T04:00:00.000Z)
Business address
500 NORTH BEACON STREET, 4TH FLOOR
WATERTOWN
MA
02472
MA
Mailing address
500 NORTH BEACON STREET, 4TH FLOOR
WATERTOWN
MA
02472
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

647 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-29 10-Q 10-Q 0001193125-26-436975 001-39460 261497463 34 12785294 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001193125-26-436965 001-39460 261497440 34 389592 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003919 005-91636 261491775 34 11155
2026-10-01 4 4 0001193125-26-410839 18598
2026-10-01 144 xsl144X01/primary_doc.xml 0001969223-26-001047 001-39460 261431445 33 5749
2026-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000601 005-91636 261363690 34 7761
2026-09-04 4 4 0001193125-26-383874 9208
2026-09-04 144 xsl144X01/primary_doc.xml 0001193125-26-383667 001-39460 261362255 33 4597
2026-09-02 144 xsl144X01/primary_doc.xml 0001950047-26-009024 001-39460 261355361 33 7220
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000572 005-91636 261277454 34 7759
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001628098-26-000009 005-91636 261274387 34 16519
2026-08-05 10-Q 10-Q 0001193125-26-333849 001-39460 261241335 34 12207226 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-333834 001-39460 261241318 34 392730 1 1
2026-07-27 4 4 0001193125-26-318408 7347
2026-07-27 3 3 0001193125-26-318404 13588
2026-07-27 8-K 8-K 5.02,7.01,9.01 0001193125-26-318078 001-39460 261205838 34 182538 1 1
2026-07-07 4 4 0001193125-26-297817 10464
2026-07-07 144 xsl144X01/primary_doc.xml 0001969223-26-000769 001-39460 261159422 33 5111
2026-07-02 4 4 0001193125-26-295090 22642
2026-07-02 4 4 0001193125-26-295089 4955
2026-07-02 4 4 0001193125-26-295088 16856
2026-07-02 4/A xslF345X06/form4a-07022026_090703.xml 0001451612-26-000022 30533
2026-07-02 144 xsl144X01/primary_doc.xml 0001969223-26-000752 001-39460 261147843 33 5111
2026-07-01 144 xsl144X01/primary_doc.xml 0001950047-26-006765 001-39460 261146249 33 9112
2026-06-30 4 xslF345X06/form4-06302026_090614.xml 0001451612-26-000020 18608
2026-06-30 4 xslF345X06/form4-06302026_090613.xml 0001451612-26-000018 56280
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006647 001-39460 261140965 33 5384
2026-06-29 144 xsl144X01/primary_doc.xml 0001628280-26-046098 001-39460 261137223 33 19711
2026-06-29 144 xsl144X01/primary_doc.xml 0001628280-26-046097 001-39460 261137221 33 19711
2026-06-26 4 OWNERSHIP DOCUMENT 0000921895-26-001688 50432
2026-06-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000921895-26-001687 005-91636 261130899 34 27044
2026-06-26 144 xsl144X01/primary_doc.xml 0000921895-26-001685 001-39460 261130851 33 4989
2026-06-26 144 xsl144X01/primary_doc.xml 0001628280-26-045808 001-39460 261130141 33 18366
2026-06-26 144 xsl144X01/primary_doc.xml 0001628280-26-045807 001-39460 261130134 33 18363
2026-06-25 4 xslF345X06/form4-06262026_010658.xml 0001451612-26-000016 42559
2026-06-25 4 xslF345X06/form4-06262026_010604.xml 0001451612-26-000015 56233
2026-06-25 4 OWNERSHIP DOCUMENT 0000921895-26-001680 47677
2026-06-25 4 4 0001193125-26-283141 5913
2026-06-25 4 4 0001193125-26-283140 5939
2026-06-25 4 4 0001193125-26-283139 9988
2026-06-25 4 4 0001193125-26-283136 5388
2026-06-25 4 4 0001193125-26-283138 5397
2026-06-25 4 4 0001193125-26-283135 5375
2026-06-25 4 4 0001193125-26-283137 5337
2026-06-25 4 4 0001193125-26-283134 5376
2026-06-25 144 xsl144X01/primary_doc.xml 0001628280-26-045610 001-39460 261123187 33 17015
2026-06-25 144 xsl144X01/primary_doc.xml 0001628280-26-045609 001-39460 261123174 33 17018
2026-06-25 4 4 0001193125-26-283039 22262
2026-06-25 144 xsl144X01/primary_doc.xml 0001950047-26-006511 001-39460 261122262 33 8393
2026-06-25 8-K 8-K 7.01,8.01,9.01 0001193125-26-281817 001-39460 261117639 34 180662 1 1
2026-06-24 144 xsl144X01/primary_doc.xml 0001628280-26-045290 001-39460 261116966 33 15669
2026-06-24 144 xsl144X01/primary_doc.xml 0001628280-26-045289 001-39460 261116958 33 15666
2026-06-24 8-K 8-K 5.07 0001193125-26-281051 001-39460 261115930 34 153386 1 1
2026-06-23 144 xsl144X01/primary_doc.xml 0001628280-26-044985 001-39460 261112482 33 14321
2026-06-23 144 xsl144X01/primary_doc.xml 0001628280-26-044984 001-39460 261112481 33 14324
2026-06-22 4 xslF345X06/form4-06232026_010614.xml 0001451612-26-000012 11769
2026-06-22 4 xslF345X06/form4-06232026_010608.xml 0001451612-26-000010 58328
2026-06-22 4 4 0001193125-26-277766 8580
2026-06-22 144 xsl144X01/primary_doc.xml 0001628280-26-044732 001-39460 261108160 33 12979
2026-06-22 144 xsl144X01/primary_doc.xml 0001628280-26-044731 001-39460 261108156 33 12982
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006382 001-39460 261107737 33 7670
2026-06-18 144 xsl144X01/primary_doc.xml 0001628280-26-044426 001-39460 261104205 33 11631
2026-06-18 144 xsl144X01/primary_doc.xml 0001628280-26-044425 001-39460 261104204 33 11633
2026-06-17 144 xsl144X01/primary_doc.xml 0001628280-26-044012 001-39460 261099535 33 9635
2026-06-17 144 xsl144X01/primary_doc.xml 0001628280-26-044011 001-39460 261099532 33 9635
2026-06-17 144 xsl144X01/primary_doc.xml 0001628280-26-044009 001-39460 261099529 33 9353
2026-06-17 144 xsl144X01/primary_doc.xml 0001950047-26-006287 001-39460 261099131 33 12285
2026-06-08 8-K 8-K 5.02 0001193125-26-261698 001-39460 261072571 34 140109 1 1
2026-06-03 4 4 0001193125-26-254589 6754
2026-05-27 4 4 0001193125-26-242266 16669
2026-05-26 144 xsl144X01/primary_doc.xml 0001950047-26-005075 001-39460 261020575 33 12201
2026-05-26 144 xsl144X01/primary_doc.xml 0001193125-26-239224 001-39460 261019588 33 11656
2026-05-19 4 4 0001193125-26-230730 6686
2026-05-19 4 4 0001193125-26-229656 6757
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000493 005-91636 26983392 34 7524
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000204 005-91636 26982316 34 15474
2026-05-11 4 4 0001193125-26-217041 8346
2026-05-11 144 xsl144X01/primary_doc.xml 0001950047-26-004332 001-39460 26963832 33 6244
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001229 005-91636 26946825 34 11336
2026-04-30 10-Q 10-Q 0001193125-26-193967 001-39460 26920053 34 10603326 1 1
2026-04-30 8-K 8-K 2.02,9.01 0001193125-26-193957 001-39460 26920038 34 353823 1 1
2026-04-29 4 4 0001193125-26-192146 12803
2026-04-29 ARS ARS 0001193125-26-191619 001-39460 26916217 34 1658174
2026-04-29 DEFA14A DEFA14A 0001193125-26-191550 001-39460 26916068 34 698987
2026-04-29 144 xsl144X01/primary_doc.xml 0001969223-26-000476 001-39460 26915934 33 5110
2026-04-29 DEF 14A DEF 14A 0001193125-26-191495 001-39460 26915811 34 6160675 1 1
2026-04-24 4 xslF345X06/form4-04242026_080445.xml 0001451612-26-000006 16989
2026-04-24 4 4 0001193125-26-177400 12243
2026-04-22 144 xsl144X01/primary_doc.xml 0001628280-26-026599 001-39460 26884478 33 8988
2026-04-22 144 xsl144X01/primary_doc.xml 0001628280-26-026598 001-39460 26884473 33 8988
2026-04-22 144 xsl144X01/primary_doc.xml 0001950047-26-003700 001-39460 26884226 33 11305
2026-04-16 4 4 0001193125-26-159539 4777
2026-04-16 4 4 0001193125-26-159538 17630
2026-04-16 4 xslF345X06/form4-04162026_100449.xml 0001451612-26-000004 19044
2026-04-15 144 xsl144X01/primary_doc.xml 0001628280-26-025281 001-39460 26864715 33 7001
2026-04-15 144 xsl144X01/primary_doc.xml 0001628280-26-025280 001-39460 26864712 33 7003
2026-04-15 144 xsl144X01/primary_doc.xml 0001950047-26-003490 001-39460 26864625 33 10586
2026-04-14 144 xsl144X01/primary_doc.xml 0001628280-26-025115 001-39460 26861727 33 6663
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003449 001-39460 26861255 33 9856
2026-04-10 4 4 0001193125-26-151393 14112
2026-04-09 144 xsl144X01/primary_doc.xml 0001193125-26-149706 001-39460 26851967 33 5468
2026-04-01 4 4 0001193125-26-138372 15653
2026-04-01 4 4 0001193125-26-138371 15956
2026-04-01 144 xsl144X01/primary_doc.xml 0001950047-26-003152 001-39460 26828978 33 5520
2026-04-01 144 xsl144X01/primary_doc.xml 0001950047-26-003151 001-39460 26828974 33 9131
2026-03-31 144 xsl144X01/primary_doc.xml 0001950047-26-003094 001-39460 26822248 33 8402
2026-03-31 144 xsl144X01/primary_doc.xml 0001950047-26-003091 001-39460 26822205 33 4794
2026-03-27 8-K 8-K 5.03,9.01 0001193125-26-129170 001-39460 26807888 34 148908 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001649 005-91636 26801871 34 7185
2026-03-25 4 4 0001193125-26-124367 21754
2026-03-23 144 xsl144X01/primary_doc.xml 0001950047-26-002913 001-39460 26782824 33 7894
2026-03-20 4 4 0001193125-26-118032 12554
2026-03-20 144 xsl144X01/primary_doc.xml 0001950047-26-002864 001-39460 26778704 33 6229
2026-03-11 4 4 0001193125-26-102630 12810
2026-03-11 144 xsl144X01/primary_doc.xml 0001950047-26-002488 001-39460 26743997 33 6804
2026-03-04 4 4 0001193125-26-091986 7079
2026-03-04 4 4 0001193125-26-091985 21139
2026-03-04 4 4 0001193125-26-091984 7149
2026-03-04 4 4 0001193125-26-091983 20944
2026-03-04 4 4 0001193125-26-091982 20934
2026-03-04 4 4 0001193125-26-091980 5349
2026-03-04 4 xslF345X05/form4-03042026_040326.xml 0001451612-26-000002 8007
2026-03-02 144 xsl144X01/primary_doc.xml 0001628280-26-013331 001-39460 26709271 33 4653
2026-03-02 144 xsl144X01/primary_doc.xml 0001628280-26-013330 001-39460 26709267 33 4656
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-085708 001-39460 26709190 33 5973
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-085705 001-39460 26709186 33 5267
2026-03-02 144 xsl144X01/primary_doc.xml 0001193125-26-085696 001-39460 26709120 33 5256
2026-02-26 8-K 8-K 1.01,1.02,8.01,9.01 0001193125-26-073561 001-39460 26681819 34 405422 1 1
2026-02-26 424B3 424B3 0001193125-26-073553 333-282912 26681811 33 643840 1 1
2026-02-26 424B5 424B5 0001193125-26-073542 333-282912 26681802 33 571770 1 1
2026-02-26 S-8 S-8 0001193125-26-073431 333-293772 26681722 33 186089 1 1
2026-02-26 10-K 10-K 0001193125-26-073395 001-39460 26681693 34 19235258 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-073386 001-39460 26681684 34 363015 1 1
2026-02-25 4 4 0001193125-26-072155 15998
2026-02-25 144 xsl144X01/primary_doc.xml 0001969223-26-000229 001-39460 26678366 33 5713
2026-02-20 4 4 0001193125-26-061686 10589
2026-02-20 144 xsl144X01/primary_doc.xml 0001950047-26-001590 001-39460 26660355 33 6231
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-26-000017 005-91636 26614221 34 17225
2026-01-20 4 4 0001193125-26-016934 15447
2026-01-20 144 xsl144X01/primary_doc.xml 0001950047-26-000560 001-39460 26543269 33 5505
2026-01-13 8-K 8-K 2.02,7.01,9.01 0001193125-26-011104 001-39460 26528390 34 188428 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000053 005-91636 26517694 34 11619
2026-01-06 4 4 0001193125-26-004641 6765
2025-12-31 4 4 0001193125-25-338415 10741
2025-12-31 144 xsl144X01/primary_doc.xml 0001969223-25-001120 001-39460 251617530 33 5714
2025-12-17 4 4 0001193125-25-323092 6636
2025-12-17 4 4 0001193125-25-323090 21308
2025-12-17 144 xsl144X01/primary_doc.xml 0001950047-25-010458 001-39460 251579577 33 4781
2025-12-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-003346 005-91636 251572787 34 27459
2025-12-12 4 xslF345X05/form4-12122025_111217.xml 0001451612-25-000014 27830
2025-12-12 144 xsl144X01/primary_doc.xml 0001178937-25-000093 001-39460 251569152 33 5783
2025-12-12 144 xsl144X01/primary_doc.xml 0001178937-25-000092 001-39460 251569056 33 5765
2025-12-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-120356 005-91636 251565881 34 26218
2025-12-11 144 xsl144X01/primary_doc.xml 0001178937-25-000090 001-39460 251565761 33 5127
2025-12-11 144 xsl144X01/primary_doc.xml 0001178937-25-000089 001-39460 251565665 33 5121
2025-12-11 4 4 0001193125-25-315999 18534
2025-12-10 144 xsl144X01/primary_doc.xml 0001178937-25-000088 001-39460 251563061 33 4472
2025-12-10 144 xsl144X01/primary_doc.xml 0001178937-25-000087 001-39460 251563049 33 4473
2025-12-10 8-K 8-K 1.01,8.01,9.01 0001193125-25-314422 001-39460 251562788 34 456942 1 1
2025-12-10 424B5 424B5 0001193125-25-314256 333-282912 251562308 33 755420 1 1
2025-12-08 4 4 0001193125-25-311505 10669
2025-12-08 4 4 0001193125-25-311504 8289
2025-12-08 4 4 0001193125-25-311503 17991
2025-12-08 144 xsl144X01/primary_doc.xml 0001969223-25-001055 001-39460 251557152 33 5715
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009969 001-39460 251557146 33 6239
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009968 001-39460 251557144 33 5520
2025-12-08 424B5 424B5 0001193125-25-311268 333-282912 251556371 33 621819
2025-12-08 8-K 8-K 7.01,9.01 0001193125-25-310670 001-39460 251554743 34 25702735 1 1
2025-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-310572 001-39460 251554627 34 224747 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-25-000835 005-91636 251483460 34 7643
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002767 005-91636 251452720 34 11432
2025-11-04 10-Q 10-Q 0001193125-25-263550 001-39460 251446441 34 12281227 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001193125-25-263540 001-39460 251446423 34 438147 1 1
2025-10-29 4 4 0001193125-25-256673 12672
2025-10-29 144 xsl144X01/primary_doc.xml 0001969223-25-000889 001-39460 251429910 33 5075
2025-10-15 4 4 0001193125-25-240430 18099
2025-10-15 144 xsl144X01/primary_doc.xml 0001950047-25-008003 001-39460 251395268 33 6267
2025-10-14 4 4 0001193125-25-239144 11772
2025-10-14 4 4 0001193125-25-238130 8738
2025-10-14 144 xsl144X01/primary_doc.xml 0001950047-25-007920 001-39460 251389674 33 5747
2025-10-14 144 xsl144X01/primary_doc.xml 0001950047-25-007916 001-39460 251389668 33 5039
2025-09-17 4 4 0001193125-25-206350 11029
2025-09-17 144 xsl144X01/primary_doc.xml 0001950047-25-007269 001-39460 251320335 33 4800
2025-09-16 4 4 0001193125-25-204997 8282
2025-09-16 144 xsl144X01/primary_doc.xml 0001969223-25-000775 001-39460 251317365 33 4473
2025-09-03 4 4 0001193125-25-195044 7186
2025-09-03 3 3 0001193125-25-195035 12716
2025-09-03 8-K 8-K 5.02,7.01,9.01 0001193125-25-194481 001-39460 251287736 34 155852 1 1
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000333 005-91636 251204890 34 17218
2025-08-11 10-Q 10-Q 0000950170-25-106229 001-39460 251200152 34 12400517 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106227 001-39460 251200138 34 451098 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003210 005-91636 251132369 34 11066
2025-07-01 4 OWNERSHIP DOCUMENT 0000921895-25-001910 45084
2025-06-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-064298 005-91636 251093852 34 28528
2025-06-30 4 4 0000950170-25-091829 24375
2025-06-27 8-K 8-K 1.01,8.01,9.01 0001193125-25-151393 001-39460 251087369 34 690933 1 1
2025-06-27 8-K 8-K 5.07 0001193125-25-151345 001-39460 251086904 34 147933 1 1
2025-06-27 424B5 424B5 0001193125-25-151288 333-282912 251086633 33 845088 1 1
2025-06-26 4 4 0000950170-25-090586 21783
2025-06-26 4 4 0000950170-25-090585 5265
2025-06-26 4 4 0000950170-25-090584 5805
2025-06-26 4 4 0000950170-25-090583 5242
2025-06-26 4 4 0000950170-25-090582 5203
2025-06-26 4 4 0000950170-25-090581 5779
2025-06-26 4 4 0000950170-25-090580 5241
2025-06-26 4 4 0000950170-25-090579 5263
2025-06-25 424B5 424B5 0001193125-25-146933 333-282912 251073859 33 661307
2025-06-25 8-K 8-K 7.01,8.01,9.01 0001193125-25-146135 001-39460 251070870 34 171169 1 1
2025-06-25 8-K 8-K 7.01,8.01,9.01 0001193125-25-146134 001-39460 251070869 34 203095 1 1
2025-06-11 4 4 0000950170-25-084893 8383
2025-06-11 144 xsl144X01/primary_doc.xml 0001950047-25-004153 001-39460 251040338 33 5522
2025-06-03 4 4 0000950170-25-081201 8687
2025-06-03 4 4 0000950170-25-081200 9614
2025-06-03 4 4 0000950170-25-081199 8471
2025-06-03 4 4 0000950170-25-081198 8213
2025-06-03 144 xsl144X01/primary_doc.xml 0001969223-25-000389 001-39460 251020143 33 4473
2025-06-03 144 xsl144X01/primary_doc.xml 0001950047-25-003755 001-39460 251019940 33 4797
2025-06-03 144 xsl144X01/primary_doc.xml 0001950047-25-003753 001-39460 251019909 33 4778
2025-06-03 144 xsl144X01/primary_doc.xml 0001950047-25-003751 001-39460 251019901 33 4799
2025-06-02 8-K 8-K 7.01,9.01 0001193125-25-132838 001-39460 251013218 34 18991717 1 1
2025-06-02 8-K 8-K 7.01,8.01,9.01 0001193125-25-132760 001-39460 251013111 34 200190 1 1
2025-05-23 4 4 0000950170-25-076993 5498
2025-05-23 144 xsl144X01/primary_doc.xml 0000950170-25-076959 001-39460 25982573 33 5349
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000224 005-91636 25933456 34 17205
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001543 005-91636 25933275 34 11450
2025-05-09 10-Q 10-Q 0000950170-25-067498 001-39460 25928369 34 10703538 1 1
2025-05-09 8-K 8-K 2.02,7.01,9.01 0001193125-25-116443 001-39460 25928334 34 252261 1 1
2025-05-07 UPLOAD filename1.pdf 0000000000-25-004854 001-39460 39582
2025-04-30 CORRESP filename1.htm 0001193125-25-107469 9728
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000559 005-91636 25892128 34 6224
2025-04-29 ARS ARS 0001193125-25-103840 001-39460 25887914 34 1684479
2025-04-29 DEFA14A DEFA14A 0001193125-25-103788 001-39460 25887630 34 717007
2025-04-29 DEF 14A DEF 14A 0001193125-25-103767 001-39460 25887142 34 1984988 1 1
2025-04-25 UPLOAD filename1.pdf 0000000000-25-004415 001-39460 43056
2025-04-09 4 4 0000950170-25-052310 7244
2025-04-09 3 3 0000950170-25-052309 15895
2025-04-01 4 4 0000950170-25-048049 6825
2025-03-03 4 4 0000950170-25-031148 11243
2025-03-03 4 4 0000950170-25-031147 11307
2025-03-03 4 4 0000950170-25-031146 11283
2025-03-03 4 4 0000950170-25-031145 5356
2025-03-03 4 4 0000950170-25-031144 11293
2025-03-03 144 xsl144X01/primary_doc.xml 0000950170-25-031101 001-39460 25700407 33 4675
2025-03-03 144 xsl144X01/primary_doc.xml 0000950170-25-031098 001-39460 25700406 33 5295
2025-03-03 144 xsl144X01/primary_doc.xml 0000950170-25-031097 001-39460 25700405 33 4657
2025-03-03 144 xsl144X01/primary_doc.xml 0000950170-25-031096 001-39460 25700404 33 4663
2025-03-03 8-K 8-K 5.02 0001193125-25-044151 001-39460 25698495 34 144761 1 1
2025-02-27 S-8 S-8 0001193125-25-037613 333-285308 25673046 33 233483 1 1
2025-02-27 10-K 10-K 0000950170-25-028355 001-39460 25672982 34 33155851 1 1
2025-02-27 8-K 8-K 2.02,5.02,9.01 0001193125-25-037588 001-39460 25672977 34 231324 1 1
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000097 005-91636 25604189 34 17239
2025-01-14 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001193125-25-006124 001-39460 25529381 34 8046783 1 1
2025-01-13 4 4 0000950170-25-004549 6807
2025-01-13 4 4 0000950170-25-004548 7024
2025-01-06 4 4 0000950170-25-002266 5496
2025-01-06 144 xsl144X01/primary_doc.xml 0000950170-25-002182 001-39460 25511594 33 4615
2024-12-02 4 4 0000950170-24-132401 8193
2024-12-02 144 xsl144X01/primary_doc.xml 0001950047-24-009322 001-39460 241519678 33 5512
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119016 005-91636 241463191 34 116912
2024-11-14 SC 13G/A kymr13gasep24.txt 0000080255-24-001463 005-91636 34 6509
2024-11-14 SC 13G/A KYMERA THERAPEUTICS, INC. 0000902664-24-006520 005-91636 241457789 34 62562
2024-11-12 SC 13G filing.txt 0000315066-24-002814 005-91636 241444878 34 8098
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000489 005-91636 241438650 34 36176
2024-10-31 S-3ASR S-3ASR 0001193125-24-248179 333-282912 241412553 33 1396286 1 1
2024-10-31 10-Q 10-Q 0000950170-24-119249 001-39460 241412479 34 10307835 1 1
2024-10-31 8-K 8-K 2.02,9.01 0000950170-24-119245 001-39460 241412464 34 401656 1 1
2024-09-17 4 4 0000950170-24-107458 14109
2024-09-17 144 xsl144X01/primary_doc.xml 0001950047-24-007187 001-39460 241304964 33 4783
2024-08-26 4 4 0000950170-24-100660 8891
2024-08-26 144 xsl144X01/primary_doc.xml 0001950047-24-006521 001-39460 241241875 33 12251
2024-08-26 144 xsl144X01/primary_doc.xml 0001950047-24-006508 001-39460 241241702 33 4806
2024-08-22 4 OWNERSHIP DOCUMENT 0000921895-24-001896 41502
2024-08-22 SC 13D/A SC 13D/A 0001104659-24-091998 005-91636 241232173 34 116748
2024-08-22 4 4 0000950170-24-099827 23919
2024-08-20 8-K 8-K 1.01,8.01,9.01 0001193125-24-203755 001-39460 241226349 34 584777 1 1
2024-08-20 424B5 424B5 0001193125-24-203691 333-259955 241225636 33 821399 1 1
2024-08-19 424B5 424B5 0001193125-24-202805 333-259955 241220355 33 636436
2024-08-07 10-Q 10-Q 0000950170-24-092275 001-39460 241181419 34 9600476 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092272 001-39460 241181407 34 400744 1 1
2024-07-25 144 xsl144X01/primary_doc.xml 0000950170-24-086674 001-39460 241143137 33 5627
2024-07-23 144 xsl144X01/primary_doc.xml 0000950170-24-085753 001-39460 241135468 33 4947
2024-07-16 4 4 0000950170-24-084003 16292
2024-07-16 144 xsl144X01/primary_doc.xml 0001950047-24-005451 001-39460 241119946 33 5529
2024-07-15 144 xsl144X01/primary_doc.xml 0001950047-24-005419 001-39460 241117639 33 4795
2024-07-09 4 xslF345X05/form4-07092024_090724.xml 0001415889-24-019440 21872
2024-07-09 144 xsl144X01/primary_doc.xml 0001961863-24-000219 001-39460 241107659 33 7178
2024-07-09 144 xsl144X01/primary_doc.xml 0001961863-24-000218 001-39460 241107644 33 7181
2024-07-08 8-K 8-K 7.01,8.01,9.01 0001193125-24-176312 001-39460 241104982 34 168349 1 1
2024-07-01 4 4 0000950170-24-079666 6807
2024-06-28 4 OWNERSHIP DOCUMENT 0000921895-24-001488 37919
2024-06-28 4 4 0000950170-24-078790 7032
2024-06-20 8-K 8-K 5.02,5.07,9.01 0001193125-24-164550 001-39460 241057311 34 175886 1 1
2024-06-20 4 4 0000950170-24-075705 5252
2024-06-20 4 4 0000950170-24-075713 5792
2024-06-20 4 4 0000950170-24-075712 5275
2024-06-20 4 4 0000950170-24-075711 5273
2024-06-20 4 4 0000950170-24-075710 5815
2024-06-20 4 4 0000950170-24-075709 5213
2024-06-20 4 4 0000950170-24-075708 5268
2024-06-20 4 4 0000950170-24-075707 5251
2024-06-20 4 4 0000950170-24-075332 7003
2024-06-14 4 xslF345X05/form4-06142024_100645.xml 0001415889-24-017005 15036
2024-06-13 144 xsl144X01/primary_doc.xml 0001961863-24-000217 001-39460 241042154 33 9775
2024-06-13 144 xsl144X01/primary_doc.xml 0001961863-24-000216 001-39460 241042148 33 9776
2024-06-12 144 xsl144X01/primary_doc.xml 0001961863-24-000215 001-39460 241039383 33 8480
2024-06-12 144 xsl144X01/primary_doc.xml 0001961863-24-000214 001-39460 241039373 33 8483
2024-06-07 4 4 0000950170-24-070966 10782
2024-06-07 144 xsl144X01/primary_doc.xml 0001950047-24-004524 001-39460 241029936 33 4760
2024-05-23 144 xsl144X01/primary_doc.xml 0000950170-24-064046 001-39460 24979729 33 4677
2024-05-23 4 4 0000950170-24-063947 5321
2024-05-02 10-Q 10-Q 0000950170-24-051567 001-39460 24905263 34 8655363 1 1
2024-05-02 8-K 8-K 2.02,9.01 0000950170-24-051566 001-39460 24905245 34 327616 1 1
2024-04-24 ARS ARS 0001193125-24-110118 001-39460 24870772 34 4717226
2024-04-24 DEFA14A DEFA14A 0001193125-24-110092 001-39460 24870674 34 887940
2024-04-24 DEF 14A DEF 14A 0001193125-24-110064 001-39460 24870580 34 2523074 1 1
2024-04-01 SC 13D SC 13D 0001104659-24-041578 005-91636 24805794 34 119945
2024-04-01 4 4 0000950170-24-038905 21542
2024-04-01 3 3 0000950170-24-038903 13395
2024-04-01 8-K 8-K 5.02 0001193125-24-082641 001-39460 24805497 34 147931 1 1
2024-03-15 4 xslF345X05/form4-03152024_110334.xml 0001415889-24-008155 25303
2024-03-15 144 xsl144X01/primary_doc.xml 0001961863-24-000120 001-39460 24755267 33 9759
2024-03-15 144 xsl144X01/primary_doc.xml 0001961863-24-000119 001-39460 24755248 33 9781
2024-03-14 144 xsl144X01/primary_doc.xml 0001961863-24-000116 001-39460 24751153 33 8467
2024-03-14 144 xsl144X01/primary_doc.xml 0001961863-24-000115 001-39460 24751144 33 8484
2024-03-13 4 xslF345X05/form4-03132024_110341.xml 0001415889-24-007894 34688
2024-03-13 4 xslF345X05/form4-03132024_110328.xml 0001415889-24-007890 25302
2024-03-13 144 xsl144X01/primary_doc.xml 0001961863-24-000108 001-39460 24746756 33 7186
2024-03-13 144 xsl144X01/primary_doc.xml 0001961863-24-000107 001-39460 24746741 33 7177
2024-03-12 144 xsl144X01/primary_doc.xml 0001961863-24-000104 001-39460 24743382 33 6410
2024-03-12 144 xsl144X01/primary_doc.xml 0001961863-24-000102 001-39460 24743159 33 5884
2024-03-11 144 xsl144X01/primary_doc.xml 0001961863-24-000089 001-39460 24738995 33 4587
2024-03-11 144 xsl144X01/primary_doc.xml 0001961863-24-000088 001-39460 24738964 33 4584
2024-03-04 4 4 0000950170-24-025101 13230
2024-03-04 4 4 0000950170-24-025097 7201
2024-03-04 4 4 0000950170-24-025093 7140
2024-03-04 4 4 0000950170-24-025085 5359
2024-03-04 4 4 0000950170-24-025083 13221
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025038 001-39460 24716731 33 6053
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025031 001-39460 24716695 33 4677
2024-02-29 4 4 0000950170-24-023168 8436
2024-02-27 144 xsl144X01/primary_doc.xml 0001950047-24-001449 001-39460 24687150 33 5521
2024-02-22 S-8 S-8 0001193125-24-042097 333-277242 24662308 33 69954
2024-02-22 10-K 10-K 0000950170-24-018414 001-39460 24662285 34 24520992 1 1
2024-02-22 8-K 8-K 2.02,9.01 0000950170-24-018413 001-39460 24662275 34 340292 1 1
2024-02-21 4 4 0000950170-24-018246 14243
2024-02-21 144 xsl144X01/primary_doc.xml 0001950047-24-001213 001-39460 24659902 33 6250
2024-02-20 144 xsl144X01/primary_doc.xml 0001950047-24-001140 001-39460 24654006 33 5524
2024-02-14 SC 13G/A KYMERA THERAPEUTICS, INC. 0000902664-24-001602 005-91636 24632993 34 58671
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021310 005-91636 24628862 34 13077
2024-02-12 SC 13G/A kymr13gajan24.txt 0000080255-24-000633 005-91636 34 7116
2024-02-12 SC 13G/A kymr13gadec23.txt 0000080255-24-000615 005-91636 34 6517
2024-02-09 4 4 0000950170-24-013482 10862
2024-02-09 144 xsl144X01/primary_doc.xml 0001950047-24-000801 001-39460 24615342 33 4794
2024-02-09 SC 13G/A SC 13G/A 0001104659-24-012917 005-91636 24614667 34 112714
2024-02-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000184 005-91636 24607390 34 37886
2024-01-29 SC 13G/A us5015751044_012924.txt 0001086364-24-005192 005-91636 24573195 34 13697
2024-01-23 4 4 0000950170-24-006766 8897
2024-01-23 144 xsl144X01/primary_doc.xml 0001950047-24-000428 001-39460 24552896 33 4803
2024-01-23 SC 13G/A Kymera_Th_Inc.txt 0000093751-24-000096 005-91636 24550871 34 8523
2024-01-10 SC 13G/A SC 13G/A 0001104659-24-002999 005-91636 24527117 34 91960
2024-01-09 4 OWNERSHIP DOCUMENT 0000921895-24-000071 38449
2024-01-09 SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 0000921895-24-000070 005-91636 24523801 34 319464
2024-01-05 4 4 0000950170-24-002536 5258
2024-01-05 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-24-003373 001-39460 24516346 34 586434 1 1
2024-01-05 424B5 424B5 0001193125-24-003347 333-259955 24516181 33 693800
2024-01-04 424B5 424B5 0001193125-24-002435 333-259955 24511836 33 667144
2024-01-04 8-K 8-K 7.01,9.01 0001193125-24-002424 001-39460 24511724 34 32009304 1 1
2024-01-04 144 xsl144X01/primary_doc.xml 0000950170-24-001531 001-39460 24509957 33 4612
2024-01-04 8-K 8-K 7.01,8.01,9.01 0001193125-24-001884 001-39460 24509745 34 197424 1 1
2024-01-02 4 4 0000950170-24-000386 6808
2023-11-06 4 OWNERSHIP DOCUMENT 0000921895-23-002475 38634
2023-11-06 4 4 0000950170-23-059580 10378
2023-11-02 8-K 8-K 7.01,8.01,9.01 0001193125-23-268944 001-39460 231370358 34 183972 1 1
2023-11-02 10-Q 10-Q 0000950170-23-057743 001-39460 231370057 34 10742357 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001193125-23-268815 001-39460 231370043 34 235231 1 1
2023-08-08 4 4 0000950170-23-039894 6915
2023-08-03 10-Q 10-Q 0000950170-23-037581 001-39460 231138049 34 11819749 1 1
2023-08-03 8-K 8-K 2.02,9.01 0000950170-23-037578 001-39460 231138033 34 409259 1 1
2023-06-20 4 OWNERSHIP DOCUMENT 0000921895-23-001547 32185
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015969 5396
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015967 5413
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015965 5358
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015968 5418
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015966 5937
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015963 5371
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015964 5420
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015961 5397
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015960 5960
2023-06-16 8-K 8-K 5.07 0001193125-23-168977 001-39460 231021041 34 157808 1 1
2023-06-05 SC 13D/A SCHEDULE 13D - AMENDMENT NO. 1 0001341004-23-000148 005-91636 23992565 34 48114
2023-06-02 4 4 0000950170-23-025989 6758
2023-05-22 4 4 0000950170-23-023515 7207
2023-05-22 3 FORM 3 SUBMISSION 0000899243-23-013622 7605
2023-05-22 8-K 8-K 5.02,7.01,9.01 0001193125-23-150555 001-39460 23945195 34 175655 1 1
2023-05-04 10-Q 10-Q 0000950170-23-017462 001-39460 23886443 34 10454005 1 1
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017458 001-39460 23886428 34 375406 1 1
2023-04-27 ARS ARS 0001193125-23-122199 001-39460 23857079 34 17483491
2023-04-27 DEFA14A DEFA14A 0001193125-23-122156 001-39460 23856943 34 714405
2023-04-27 DEF 14A DEF 14A 0001193125-23-122116 001-39460 23856812 34 2247221 1 1
2023-03-10 8-K 8-K 7.01 0001193125-23-067797 001-39460 23724998 34 147672 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (215 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 85.37M 2026-10-23 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
dei EntityPublicFloat Entity Public Float USD 2.29B 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 10.08M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.77M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 27.85M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
ecd PeoTotalCompAmt PeoTotalCompAmt USD 8.55M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 125.5 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191495
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 11.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 20.00M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333849
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 63.31M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 13.35M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 28.11M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -14.73M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.96B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 53.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 53.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 3.85M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263550
us-gaap Assets Assets USD 1.77B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AssetsCurrent Assets, Current USD 998.59M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 6,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 14.72M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.29B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.27B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 597.84M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 674.67M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap AvailableforsaleSecuritiesSoldAtPar Debt Securities, Available-for-sale, Sold at Par Value USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-057743
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 373.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 379.58M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 16.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 85.33M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 85.33M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -278.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263550
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ContractWithCustomerReceivableAfterAllowanceForCreditLoss Contract with Customer, Receivable, after Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap CostOfRevenue Cost of Revenue USD 99.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Security 370 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredRevenue Deferred Revenue USD 3.70M 2025-03-31 2025 Q1 10-Q 2025-05-09 0000950170-25-067498
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 351.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 21.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 159.31M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 46.47M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 15.06M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 54.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 18.63M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 330.29M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 21.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 68.34M 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018414
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 10.63M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap Depreciation Depreciation USD 4.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 6.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001860
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.71 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0000950170-22-006947
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.232 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.023 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018414
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-015745
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-015745
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 169,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 861,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.97M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 602,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 2.11M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 72,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 449,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 411,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 139,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 169,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 1.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.089 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018414
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 60.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap GeneralPartnersOfferingCosts General Partners' Offering Costs USD 149.80M 2022-08-18 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap ImpairmentChargeOnReclassifiedAssets Impairment Charge on Reclassified Assets USD 8.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 3.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -311.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -311.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 72.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -65.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 122,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -9.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -99,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -6.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 7.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -577,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001860
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 21.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -34.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 20.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333849
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net USD 32,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050872
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -650,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 143,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024514
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap InterestExpenseOther Interest Expense, Other USD 203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap InterestIncomeOther Interest Income, Other USD 44.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap InvestmentsAndCash Investments and Cash USD 1.65B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LeaseCost Lease, Cost USD 13.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 103.56M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 49.30M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 12.81M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 11.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 11.53M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 13.59M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 13.19M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 28.93M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap Liabilities Liabilities USD 152.74M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.77B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap LiabilitiesCurrent Liabilities, Current USD 89.72M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 258.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -21.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -220.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -262.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -262.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingExpenses Operating Expenses USD 406.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -306.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 74.63M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 12.21M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 62.42M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 40.44M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.087 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 211.50M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 227,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 9.11M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -16.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -16.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 905,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 44.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 44.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 88.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018414
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 16.21M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018414
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 451.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 1.01B 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 27.38M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-003935
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 488.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 431.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 215.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 43.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -262.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 66.35M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 38.24M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 346.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap RestrictedCash Restricted Cash USD 6.21M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.79M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050872
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 6.21M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.33B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 99.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 51.40M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028355
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 53.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.77 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.61B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.595 2020-08-20 2022 FY 10-K 2023-02-23 0000950170-23-003935
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 211.33M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-23 0000950170-23-003935
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 43.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-003935
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 6.537 2020-03-31 2021 Q3 10-Q 2021-11-10 0000950170-21-003911
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 120.10M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-003935
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 94.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-073395
us-gaap VariableLeaseCost Variable Lease, Cost USD 4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 98.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 51.65M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0000950170-22-006947
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 98.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436975

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →